SKY-0515

Huntington's disease

Manufacturer: Skyhawk Therapeutics
Regulatory submission: TGA provisional approval application submitted March 2026
Launch: Anticipated as early as 2027, market not specified
Last updated: October 1, 2026

Section

Product information and disease description Product description Product information

Dosing and administration

6 evidence topics · 5 sources